Join ABL at PEGS in Boston
Boston, MA—March 11, 2016 – ABL will be at the 12th Annual PEGS Boston conference at the Seaport World Trade Center from April 25-29. PEGS is a protein engineering summit with 8 streams for presentations and discussions:
- Engineering
- Oncology
- Immunotherapy
- Expression
- Analytical
- Immunogenicity & Bioassays
- Bioconjugates
- Therapeutics
Visit ABL at Booth 106 to discuss our immunoassay and protein manufacturing capabilities.
About ABL, Inc.
ABL, Inc. is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics and other biologic products. ABL has extensive experience working with diverse organizations, including the U.S. Government, biopharmaceutical companies and academic entities. Notable contract manufacturing services include process and assay development, cGMP biologics manufacturing of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC analytics in the U.S. and Europe. ABL also maintains U.S. and European immunological and molecular laboratories to support preclinical and GCLP clinical sample processing and testing. ABL is a part of the Institut Mérieux, a group of companies dedicated to developing translational science for better patient care globally.
For more information visit www.ablinc.com or email us.
